248 filings
Page 4 of 13
CORRESP
9j4srj3jcvojywdq19j
20 May 10
Correspondence with SEC
12:00am
CORRESP
3url5is atx
18 May 10
Correspondence with SEC
12:00am
UPLOAD
5j7d24
10 May 10
Letter from SEC
12:00am
8-K
0lc 1sjht9
6 May 10
Entry into a Material Definitive Agreement
12:00am
8-K
yqyrvp2b
29 Apr 10
SCOLR Pharma, Inc. Reports First Quarter 2010 Financial Results
12:00am
8-K
fvn6rctifa1 qk6he
28 Apr 10
Regulation FD Disclosure
12:00am
8-K
gomnnc92
24 Mar 10
SCOLR Pharma, Inc. Reports 2009 Full-Year Financial Results
12:00am
8-K
setyr
24 Mar 10
Termination of a Material Definitive Agreement
12:00am
D
6fz2t70sr8i5g
18 Mar 10
$4.13M in equity / options, sold $4.13M, 123 investors
12:00am
8-K
tqapy 3rfbwg3fxk
16 Mar 10
SCOLR Pharma Acquires the Rights to NuprinĀ® from CVS
12:00am
8-K
pfu2tq6
15 Mar 10
Entry into a Material Definitive Agreement
12:00am
8-K
eza1vusju83m
8 Mar 10
Regulation FD Disclosure
12:00am
8-K
ww960z 4ju
18 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
13juhtk2ghx j9owwmm
4 Jan 10
Entry into a Material Definitive Agreement
12:00am
8-K
ctfe4ej9shc7 35
16 Dec 09
Departure of Directors or Certain Officers
12:00am